CLINICAL EVOLUTION OF SARS-CoV-2 SYNDROME IN A PATIENT WITH HYPERTENSION, TYPE II DIABETES AND METABOLIC SYNDROME – CASE REPORT

• Autor(a) principal: Souza Poubel de Paula, Renata Souza
• Data de Publicação: 2020
• Outros Autores: Hübner Freitas dos Santos Silva Machado, Marina, Beber Machado, Bruno, Paiva Moraes, Augusto, Batista Marques Junior, Roberto
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Científica da Faculdade de Medicina de Campos
• Texto Completo: https://www.fmc.br/ojs/index.php/RCFMC/article/view/421
• topic: covid-19; vidro fosco; obesidade; ventilação não invasiva.; covid-19; frosted glass; obesity; non-invasive ventilation.

Abastract Introduction: The Covid-19 pandemic has brought a race to find a cure for SARS-CoV-2 infections. The most reported symptoms are fever, cough, dyspnoea and breathing difficulties, although many cases have been declared asymptomatic. There is a great investment in science and technology at this moment and, also, many questions about ethics in conducting these researches. Objective: The objective of this study is to describe the evolution of SARS-CoV-2 syndrome in the patient and the measures taken during his treatment. Methodology: The method used was a case report of a patient diagnosed with Covid-19, with hypertension, type II diabetes and metabolic syndrome, with significant pulmonary impairment and diffuse ground-glass infiltration, who progressed to hospitalization in the intensive care unit - ICU. The prone position protocol, recommended for the treatment of patients affected by Covid-19, cannot be used during hospitalization, due to its obesity. Results: The patient presented hypoxemia associated with dyspnea, with episodes of desaturation, with the need for oxygen therapy and non-invasive ventilation on a constant basis, using an O2 nasal cannula. Conclusion: The prone position is safe and should be used whenever possible because it favors a positive response to treatment, however, the patient recovered from the condition without performing it. It is essential to monitor the patient, as well as monitor the pulmonary evolution of the disease, using imaging tests.